#ESCCongress – [Abstract Only] Randomized Trial: Prasugrel Better than Ticagrelor for Patients with Acute Coronary Syndrome with Planned Invasive Evaluation
2 Sep, 2019 | 00:59h | UTCTicagrelor or Prasugrel in Patients with Acute Coronary Syndromes – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Prasugrel cuts ischaemic events in acute coronary syndrome patients – European Society of Cardiology (free) AND Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5 – TCTMD (free) AND Intracoronary Stenting and Antithrombotic Regimen 5 – ISAR-REACT 5 – American College of Cardiology (free)
Related Commentary on Twitter
ISAR-REACT 5 presented at #ESCCongress and published in @NEJM:
4000 pats with ACS randomized to Ticagrelor vs Prasugrel:
comp endpoint (death/MI/stroke) 9.3% for Tica, 6.9% for Prasugrel (driven by MI), similar bleeding.well, thats something! https://t.co/JcLkJTRhAw pic.twitter.com/PNxdsM0lik
— Konstantin Krychtiuk (@krychtiukmd) September 1, 2019